Aclaris Therapeutics (ACRS) Prepaid Assets (2014 - 2025)
Aclaris Therapeutics (ACRS) posted quarterly Prepaid Assets of $4.2 million for Q2 2025, down 32.41% year-over-year from $6.2 million in Q2 2024, and up 30.25% quarter-over-quarter from $3.2 million in Q1 2025.
Aclaris Therapeutics (ACRS) Prepaid Assets (2014 - 2025) Analysis & Trends
Aclaris Therapeutics' Prepaid Assets history runs 12 years deep, the most recent figure standing at $4.2 million for Q2 2025.
- In Q2 2025, Prepaid Assets fell 32.41% year-over-year to $4.2 million; the TTM figure through Jun 2025 stood at $4.2 million (down 32.41% YoY), while the FY2024 annual figure was $12.0 million, up 27.37% from the prior year.
- Prepaid Assets for Q2 2025 stood at $4.2 million, up from $3.2 million in the prior quarter.
- The five-year high for Prepaid Assets was $19.7 million in Q3 2023, with the low at $3.2 million in Q1 2025.
- The 5-year median for Prepaid Assets is $9.0 million (2021), against an average of $9.3 million.
- The sharpest annual moves came in 2021 and 2024: Prepaid Assets jumped 401.74% in 2021, then plunged 78.32% in 2024.
- Aclaris Therapeutics' Prepaid Assets stood at $13.0 million in 2021, then grew by 3.85% to $13.5 million in 2022, then slipped by 29.96% to $9.5 million in 2023, then rose by 27.37% to $12.0 million in 2024, then plunged by 65.1% to $4.2 million in 2025.
- Business Quant data shows ACRS's Prepaid Assets at $4.2 million in Q2 2025, $3.2 million in Q1 2025, and $12.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Aclaris Therapeutics | 808.18 Mn | 716.63 Mn | 1.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4.20 Mn |
| Mar 31, 2025 | 3.23 Mn |
| Dec 31, 2024 | 12.04 Mn |
| Sep 30, 2024 | 4.27 Mn |
| Jun 30, 2024 | 6.22 Mn |
| Mar 31, 2024 | 6.80 Mn |
| Dec 31, 2023 | 9.45 Mn |
| Sep 30, 2023 | 19.67 Mn |
| Jun 30, 2023 | 12.73 Mn |
| Mar 31, 2023 | 12.87 Mn |
| Dec 31, 2022 | 13.50 Mn |
| Sep 30, 2022 | 7.91 Mn |
| Jun 30, 2022 | 10.11 Mn |
| Mar 31, 2022 | 10.63 Mn |
| Dec 31, 2021 | 13.00 Mn |
| Sep 30, 2021 | 7.09 Mn |
| Jun 30, 2021 | 8.65 Mn |
| Mar 31, 2021 | 5.39 Mn |
| Dec 31, 2020 | 2.59 Mn |
| Sep 30, 2020 | 1.88 Mn |